Xavier Paoletti

12PUBLICATIONS
134CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)ChemotherapyPredictive and prognostic markersPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Sep 15, 2026
SHIVA02 Trial: Using Patients as Their Own Controls to Assess Efficacy of Therapies Based on Molecular Profiling in Patients with Refractory Cancer.

|Jan 27, 2026
Phase I/II Study of the PARP Inhibitor Olaparib and Irinotecan in Children and Young Adults with Recurrent/Refractory Malignancies: Arm D of the AcSé-ESMART Trial.

Susanne A Gatz, Pablo Berlanga, Gwénaël Le Teuff

|May 14, 2024
Evolution of the Innovative Therapies for Children With Cancer Consortium Trial Portfolio for Drug Development for Children With Cancer.

Francisco Bautista, Jaime Verdú-Amorós, Birgit Geoerger

|Dec 05, 2023
Phase I/II Study of the WEE1 Inhibitor Adavosertib (AZD1775) in Combination with Carboplatin in Children with Advanced Malignancies: Arm C of the AcSé-ESMART Trial.

Susanne A Gatz, Anne C Harttrampf, Caroline Brard

|Jul 19, 2023
Individual Participant Data Network Meta-Analysis of Neoadjuvant Chemotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Junction Carcinoma.

Matthieu Faron, Maurice Cheugoua-Zanetsie, Jayne Tierney

|Apr 04, 2023
Combination Early-Phase Trials of Anticancer Agents in Children and Adolescents.

Lucas Moreno, Steven G DuBois, Julia Glade Bender

Pageof 2

Frequent Collaborators

5 joint publications

Birgit Geoerger

4 joint publications

Nicolas Andre

4 joint publications

Gilles Vassal

3 joint publications

Susanne A Gatz